Sign up to save your podcasts
Or
Share Pure Global: Jakarta's MedTech Registration & The Sudden Local Content Trap
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pure Global: Jakarta's MedTech Registration & The Sudden Local Content Trap
This week on ASEAN MedTech Insights, we dissect the sudden and impactful expansion of Indonesia's local content requirements (TKDN) for medical devices. The government's unexpected decision to mandate 40% local sourcing for new categories of diagnostic imaging equipment has left many foreign manufacturers in a state of regulatory paralysis, forcing an immediate rethink of their market access strategies.
We explore the ripple effects of this policy, which goes beyond simple assembly to include local R&D and services. This episode provides a critical analysis of the strategic dilemmas now facing MedTech firms, from costly supply chain overhauls to the risks of hastily formed local partnerships, and what this signals for the future of ASEAN market harmonization.
**Key Questions Answered:**
* What are the specifics of Indonesia's newly expanded TKDN rules for medical devices?
* Why does an immediate effectivity date turn a regulatory hurdle into a strategic crisis?
* How can a company even begin to calculate a 40% local content score for a complex device?
* What are the immediate options for a foreign firm whose existing product registration is now blocked?
* Does this protectionist move undermine the ASEAN Medical Device Directive (AMDD)?
* What are the hidden dangers of quickly finding a local manufacturing partner under pressure?
* Could this policy be a blueprint for other ASEAN countries?
Navigating sudden market access barriers like Indonesia's TKDN is precisely where Pure Global excels. We provide end-to-end regulatory consulting, leveraging our local expertise and advanced data tools to build resilient strategies for MedTech and IVD companies. Don't let regulatory surprises derail your expansion. Contact us at [email protected] or visit https://pureglobal.com/ to secure your presence in over 30 global markets.
View all episodes
By Ran ChenThis week on ASEAN MedTech Insights, we dissect the sudden and impactful expansion of Indonesia's local content requirements (TKDN) for medical devices. The government's unexpected decision to mandate 40% local sourcing for new categories of diagnostic imaging equipment has left many foreign manufacturers in a state of regulatory paralysis, forcing an immediate rethink of their market access strategies.
We explore the ripple effects of this policy, which goes beyond simple assembly to include local R&D and services. This episode provides a critical analysis of the strategic dilemmas now facing MedTech firms, from costly supply chain overhauls to the risks of hastily formed local partnerships, and what this signals for the future of ASEAN market harmonization.
**Key Questions Answered:**
* What are the specifics of Indonesia's newly expanded TKDN rules for medical devices?
* Why does an immediate effectivity date turn a regulatory hurdle into a strategic crisis?
* How can a company even begin to calculate a 40% local content score for a complex device?
* What are the immediate options for a foreign firm whose existing product registration is now blocked?
* Does this protectionist move undermine the ASEAN Medical Device Directive (AMDD)?
* What are the hidden dangers of quickly finding a local manufacturing partner under pressure?
* Could this policy be a blueprint for other ASEAN countries?
Navigating sudden market access barriers like Indonesia's TKDN is precisely where Pure Global excels. We provide end-to-end regulatory consulting, leveraging our local expertise and advanced data tools to build resilient strategies for MedTech and IVD companies. Don't let regulatory surprises derail your expansion. Contact us at [email protected] or visit https://pureglobal.com/ to secure your presence in over 30 global markets.